Ginkgo Bioworks shareholders elect eight directors and ratify EY at 2022 annual meeting

Ginkgo Bioworks Holdings, Inc.

Quorum of 81.47% of combined Class A and Class B voting power; 859.9M Class A and 351.5M Class B shares present.
All eight director nominees elected: Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar, Harry E. Sloan.
Ratification of Ernst & Young as independent auditor for FY2022 approved with 4,365,263,156 votes for and 5,152,427 against.
Annual meeting held June 10, 2022; no other proposals or director nominations brought before shareholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.